GLUL stabilizes N-Cadherin by antagonizing <i>β</i>-Catenin to inhibit the progresses of gastric cancer.

Authors:
Jiang Q; Li Y; Cai S; Shi X; Yang Y and 7 more

Journal:
Acta Pharm Sin B

Publication Year: 2023

DOI:
10.1016/j.apsb.2023.11.008

PMCID:
PMC10840430

PMID:
38322340

Journal Information

Full Title: Acta Pharm Sin B

Abbreviation: Acta Pharm Sin B

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare no conflicts of interest."

Evidence found in paper:

"This work was supported by funds from the 10.13039/501100012166National Key Research and Development Program of China No. 2017YFA0505104 (Zhi Shi), the 10.13039/501100001809National Natural Science Foundation of China Nos. 81772540 and 82272996 (Zhi Shi), the Science and Technology Program of Guangdong No. 2019A050510023 (Zhi Shi, China) and the Science and Technology Program of Guangzhou No. 202206010081 (Zhi Shi, China)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025